about
Telephone delivered interventions for reducing morbidity and mortality in people with HIV infectionTelephone delivered interventions for reducing morbidity and mortality in people with HIV infectionAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionStem-cell-based gene therapy for HIV infectionAnimal Models for HIV Cure ResearchResource Effective Strategies to Prevent and Treat Cardiovascular DiseaseHIV infection, aging, and immune function: implications for cancer risk and preventionRecent developments in human immunodeficiency virus-1 latency researchIL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques.HIV-1 Protease-Substrate Coevolution in Nelfinavir ResistanceDrug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 ProteaseTherapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTInhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNADifferent distribution of HIV-1 subtype and drug resistance were found among treatment naïve individuals in Henan, Guangxi, and Yunnan province of ChinaPre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradicationFrom end of life to chronic care: the provision of community home-based care for HIV and the adaptation to new health care demands in Zambia.Point of Care Technologies for HIVGeneration and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.Genetic Modulation Therapy Through Stem Cell Transplantation for Human Immunodeficiency Virus 1 Infection.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Overcoming Barriers to HIV Treatment Adherence: A Brief Cognitive Behavioral Intervention for HIV-Positive Adults on Antiretroviral Treatment.Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human bloodImproving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendationsRisks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation.Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysisEffect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with menRapid screening of HIV reverse transcriptase and integrase inhibitors.Resistance evolution in HIV - modeling when to intervene.Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat proteinA lateral flow assay for quantitative detection of amplified HIV-1 RNA.Small-molecule APOBEC3G DNA cytosine deaminase inhibitors based on a 4-amino-1,2,4-triazole-3-thiol scaffold.Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV.The search for host genetic factors of HIV/AIDS pathogenesis in the post-genome era: progress to date and new avenues for discovery.Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study.Changes in metabolic syndrome status after initiation of antiretroviral therapyAlcohol and adherence to antiretroviral medications: interactive toxicity beliefs among people living with HIV.Immune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study.Stem cell-based anti-HIV gene therapy.
P2860
Q24202803-957DADF1-A539-45B4-ADB3-7A87C7143C57Q24234249-A63AAE0B-4800-4B32-89A5-F68D5158CA71Q24235500-EAF2D031-00FD-4ECF-99C3-7CD24F0A9136Q24607667-65A7667A-0492-425F-BF9A-07808B6C1F13Q26767476-8A3DB7B5-1292-404A-9F09-30E1F98406BEQ26768304-32F4D00E-F513-49A6-8FBE-41E0160371EEQ27004165-59F2D3C9-8335-4326-9A2C-E2A0A743E3BDQ27013114-C8801296-3AC2-4712-B4CC-A9AA1678DE90Q27320132-D10F693A-D52A-4B01-92C8-6D1E4CF9BC94Q27683192-DDCD2AC8-D54F-4B63-B68D-F000559B1F85Q27684933-582DE962-3F9D-47C4-91CC-A0EDAD541A5AQ28476094-5CFD8F41-D8EE-474A-B574-B9E33638EC04Q28478188-1349F8B4-ED57-4393-8495-400E0783A76AQ28534045-52502E9C-A8A9-4EA8-AA47-389B61ED4CC5Q28731318-AC401E8D-7750-45FE-BC1F-ADFD1C58FDC4Q30392346-D29E53F4-DF51-456A-8861-883C7759D62BQ30442547-545AEC5D-124B-412D-9AA9-EADF7C078718Q31106756-AFAF61A2-893E-4F61-A061-DA9F646E970AQ33563686-B1D40EE9-4B07-4CA9-B60E-4296145382F3Q33611645-6A41BAF3-8487-418E-A215-FAE1A6C08B90Q33621363-77728D5F-D8A5-4D19-9EDB-911D79FFB1CDQ33625213-70CBE58A-B260-47A9-AE3E-992B6EC20750Q33690506-7C1CFF57-DE79-4026-BEC8-FD9C5441830FQ33787619-FAF41F53-0563-49F4-B939-48B5811D78B3Q33841718-FF2145A2-2873-4B41-AA16-A4170A555620Q34085477-7394A042-62CA-41A2-8D8C-1FABE298F9D7Q34127575-B595D51F-9C17-49D1-A2B3-3CC020720F4FQ34193340-3C100960-81D3-49BC-86E3-851237B37C1CQ34247013-BCADEEA4-CCD1-4C9C-B5BE-83BA8F8A8FAFQ34381967-2AE21C61-864F-4810-90D1-97ED92AD3989Q34429599-114C59F5-4D05-4C04-BAC2-D50FEEF9F15EQ34488163-5F2135FA-7FD0-4AE7-93C3-05C33138FC4BQ34527341-E6C1D6E5-DC3A-44B5-9712-EB0E28DAE948Q34538784-EAC09905-1874-402C-A83F-1385B0B9C965Q34561371-54B729AF-6890-4CB0-9D11-CF0D2DBA90FFQ34661851-7A2F679B-40C0-46FD-8ACD-9AE9A9DBABBAQ34674774-07510A27-59CE-4956-90EC-60644ECF07E9Q34741832-44E90E3A-DA73-47B3-ABAC-BF70EC70F220Q34749335-4C5D80EE-44D2-4AE4-AC07-4ECA1B039A32Q34769333-8BC9F444-C8A6-489A-8BCF-EB650BF47848
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiretroviral therapy and management of HIV infection.
@en
Antiretroviral therapy and management of HIV infection.
@nl
type
label
Antiretroviral therapy and management of HIV infection.
@en
Antiretroviral therapy and management of HIV infection.
@nl
prefLabel
Antiretroviral therapy and management of HIV infection.
@en
Antiretroviral therapy and management of HIV infection.
@nl
P1433
P1476
Antiretroviral therapy and management of HIV infection.
@en
P2093
Paul A Volberding
P356
10.1016/S0140-6736(10)60676-9
P407
P577
2010-07-01T00:00:00Z